Scientific Program
The detailed interactive program contains the most up-to-date information. Have a look at the program at a glance to get an overview of the sessions waiting for you.
All times are stated in Eastern Daylight Time (EDT/GMT-4) – Washington D.C. time.
Program at a Glance
Detailed Interactive
Program
* Updated as of April 19, 2023
** Program remains subject to change.
PlenariesWorkshopsECR SessionsSatellite SymposiaHPV Advocacy & Awareness DialogieIn line with the IPVS mission of addressing the most recent advances across the spectrum of PV research, Conference topics will include:
- Expanding scientific knowledge to benefit the whole community
- Prevention of HPV infection and their associated diseases and cancers especially cervical cancer
- The epidemiology and molecular biology of PVs
- Animal models for the study of papillomavirus disease
- Basic immunology and pathogenesis of PVs
- Therapeutic and prophylactic vaccines
- Changes in screening and HPV vaccination in Japan
Our overarching theme will be “Translation of research, new discoveries and education into clinical practice and public health to eliminate HPV and related diseases globally.”
We look forward to welcoming you to Washington D.C.!
To review the scientific program and the confirmed speakers, please click on the drop-down menu below:
Opening Ceremony and IPVC Plenary Session 1
Tuesday, March 28, 2023 | 16:00 – 17:30 | Hall A
Comparing and Contrasting COVID-19 Control With HPV Control and Elimination
Barney Graham (USA)
IPVC Plenary Session 2: HPV Vaccination
Wednesday, March 29, 2023 | 11:00 – 12:30 | Hall A
One-Dose HPV Vaccination Overview and a Focus on the KENSHE Data
Ruanne Barnabas (USA)
New Prophylactic HPV Vaccines
Richard Roden (USA)
Therapeutic Vaccines in Particular With Clinical Outcomes Such As CIN 3
Mayumi Nakagawa (USA)
IPVC Plenary Session 3: Lessons Learned From Other Disease Control Programs such as HIV, Hepatitis B and Anal Cancer Control Approaches
Thursday, March 30, 2023 | 08:30 – 10:00 | Hall A
Lessons Learned From Other Disease Control Programs such as HIV
Helen Rees (South Africa)
What Can We Learn From the Hepatitis B Model in Elimination of HPV Related Diseases?
Mark Kane (USA)
Anal Cancer Control Approaches
Joel Palefsky (USA)
IPVC Plenary Session 4: Carcinogenesis of Cutaneous Papillomaviruses for Non-melanoma Skin Cancer Molecular and Immunological Aspects
Thursday, March 30, 2023 | 15:15 – 16:45 | Hall A
Mastomys coucha: a unique animal model for papillomavirus-induced skin carcinogenesis
Frank Rösl (Germany)
Pros and Cons of Beta HPVs as Causative Agents in Skin Cancer
Denise Galloway (USA)
Epidemiology and Biology of Beta Human Papillomavirus Types
Massimo Tommasino (Italy)
IPVC Plenary Session 5: COVID-19 Effect on the WHO Elimination Plan for Cervical Cancer
Friday, March 31, 2023 | 11:00 – 12:30 | Hall A
COVID-19 Effect on Cervical Screening
Mona Saraiya (USA)
Re-invigorating Efforts Towards Cervical Cancer Elimination: Mitigating the Impact of COVID-19
Karen Canfell (Australia)
What Will It Take (and How) to Achieve Cervical Cancer Elimination Goal by 2030 With a Perspective for Low to Middle-Income Countries?
Yin Ling Woo (Malaysia)
Closing Ceremony and IPVC Plenary Session 6:
Friday, March 31, 2023 | 16:30 – 18:00 | Hall A
The Future Is Now
Douglas Lowy (USA)